ArticleNeuropharmacology2026
Activation of a locus coeruleus to ventral tegmental area noradrenergic pathway blunts binge-like ethanol intake and promotes aversive unconditioned responses in TH-ires-Cre mice.
Article in Neuropharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Ethanol comprises innately aversive properties that may act as a deterrent to overconsumption. We have previously found that chemogenetic activation or inhibition of a noradrenergic locus coeruleus (LC) to rostromedial tegmental nucleus (RMTg) pathway bidirectionally modulates binge-like ethanol intake and aversive reactivity in male and female TH-ires-Cre mice. We previously hypothesized that noradrenergic RMTg circuitry may modulate ethanol intake and aversion through inhibitory inputs to the ventral tegmental area (VTA), a region that is both densely innervated by the RMTg and proposed to coordinate the balance between the rewarding and aversive properties of ethanol. Here, we build upon this work by providing evidence for a direct role of noradrenergic signaling in the VTA in the modulation of binge-like ethanol intake and unconditioned aversive responses. Using "drinking-in-the-dark" procedures, we reveal that site-directed administration of an α-1 adrenergic receptor (AR) agonist into the VTA blunts binge-like ethanol intake and associated blood ethanol concentrations (BECs) without altering sucrose consumption or locomotion. Next, we demonstrate that chemogenetic activation of noradrenergic LC to VTA projection neurons blunts binge-like ethanol intake and BECs in male and female mice without altering sucrose intake or locomotion. Further, we demonstrate that chemogenetic activation of LC to VTA projection neurons induces mid-frequency vocalizations consistent with an aversion- or malaise-like state in mice. The present findings indicate an important involvement of noradrenergic LC to VTA circuitry in the modulation of ethanol intake and aversion.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.